News


Caldan Therapeutics collaborates with Sygnature Discovery

17th May 2016 – Glasgow, UK – Caldan Therapeutics  announces that it has entered into integrated drug discovery collaboration with Sygnature Discovery Limited (Nottingham, UK). Sygnature will provide medicinal chemistry, computational sciences and informatics, bioscience and DMPK resource and intellectual input to complement Caldan’s existing capabilities and Type 2 Diabetes expertise. Click here to view Caldan’s […]

Sygnature achieves ‘The Sunday Times Heathrow SME Export Track 100’ for the 2nd year running

15th May 2016 – Nottingham, UK – We are delighted to announce that Sygnature Discovery has been placed No 65 in The Sunday Times Heathrow SME Export Track 100 published in the Business section of The Sunday Times on 15th May 2016. The listing reflects Sygnature’s continued advances in supporting the  global pharmaceutical industry with […]

Topping-out ceremony for Sygnature’s new Discovery Building

29th April 2016 – Nottingham, UK – A significant milestone was passed during  the construction of the new £30 million Discovery Building at BioCity Nottingham, which will become Sygnature Discovery’s new headquarters from March 2017. The topping-out ceremony took place on Friday 29th April 2016 with developers, contractors and Nottingham City Council (NCC) leaders coming […]

Sygnature is delighted to be hosting Kinase 2016 on 16th and 17th May 2016 in Nottingham

Organised by the SCI’s Fine Chemicals Group and the RSC’s Biological and Medicinal Chemistry sector in partnership with Sygnature Discovery,  Kinase 2016: Next Generation Inhibitors will focus on several pertinent themes including new approaches and technologies to modulate and measure kinase function in addition to diverse medicinal chemistry case studies. The 2 day event includes an […]

Adoption of IncuCyte® ZOOM enhances Sygnature Discovery’s Capabilities

16th March 2016 – Nottingham, UK – Sygnature Discovery Limited, a company which undertakes integrated drug discovery projects for pharmaceutical and biotechnology companies worldwide, from target validation to development candidate, today announced the addition of the IncuCyte® ZOOM real-time quantitative live-cell analysis technology into its Bioscience Department. In July 2015, Sygnature and Essen BioScience Ltd., […]

Page 4 of 10« First...23456...10...Last »
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.